The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The $2,630.00 order is for the drug Mounjaro 5 mg/0.5 ml pen, with a completion date of February 2, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp as the prime contractor, which serves as the primary...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $1,052.00 and a performance period through March 12, 2024. This award is a part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order in the amount of $3,156.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the procurement of the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. This delivery order, which has a completion date of January 31, 2024, is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The award has a potential value of $1,600.54 and a completion date of March 5, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00 and running...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The $1,052 contract has a period of performance through March 20, 2024. AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. doing business as AmerisourceBergen, is the prime contractor. This delivery order is part of a larger indefinite delivery contract...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation, to provide MOUNJARO 10 MG/0.5 ML PEN 0.0.5ML. The $13,469.22 delivery order has a completion date of February 1, 2024. AmerisourceBergen Drug Corp serves as the prime contractor on this order, which is part of a larger indefinite delivery contract (IDC) valued up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML pharmaceuticals. The contract has a ceiling value of $1,052.00 and a performance period through April 4, 2024. AmerisourceBergen Drug Corp is the prime contractor and the award does not utilize any set-aside designations. This delivery order is placed under an indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a $1,578 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The order is for 4,565,768,520 units of the medication Mounjaro 15 mg/0.5 ml pen. The period of performance runs through September 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025. AmerisourceBergen, one of the largest...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MOUNJARO 10 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract, valued at $1,323.67, has an ultimate completion date of March 18, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order for the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The contract has a potential value of $1,185.21 and a completion date of February 16, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will provide this medication to support military treatment programs and facilities. This delivery order is...